We are live on ! Find out more
CTSO icon

Cytosorbents Corp
CTSO

77 hedge funds and large institutions have $64.6M invested in Cytosorbents Corp in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 23 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more call options, than puts

Call options by funds: $247K | Put options by funds: $216K

13% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 23

0.6% less ownership

Funds ownership: 27.35% → 26.75% (-0.6%)

8% less capital invested

Capital invested by funds: $69.9M → $64.6M (-$5.35M)

9% less funds holding

Funds holding: 85 → 77 (-8)

53% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 15

Holders
77
Holders Change
-8
Holders Change %
-9.41%
% of All Funds
1.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
26
Reduced
23
Closed
15
Calls
$247K
Puts
$216K
Net Calls
+$31K
Net Calls Change
-$247K

Top Buyers

Rank Fund Capital Flow
1
SC
Skylands Capital
Wisconsin
+$1.09M
2
Millennium Management
Millennium Management
New York
+$765K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$516K
4
GIP
Granite Investment Partners
California
+$402K
5
GIM
Granahan Investment Management
Massachusetts
+$370K

Top Sellers

Rank Fund Capital Flow
1
MHP
Manatuck Hill Partners
Connecticut
-$1.57M
2
EI
EAM Investors
California
-$869K
3
Deutsche Bank
Deutsche Bank
Germany
-$655K
4
Renaissance Technologies
Renaissance Technologies
New York
-$646K
5
EGI
EAM Global Investors
California
-$630K
Name Holding Trade Value Shares
Change 		Change in
Stake
GT
76
Glenmede Trust
Pennsylvania
$16 – – –
MHP
77
Manatuck Hill Partners
Connecticut
– -$1.57M -194,100 Closed
EI
78
EAM Investors
California
– -$869K -107,531 Closed
EGI
79
EAM Global Investors
California
– -$630K -78,027 Closed
ARTA
80
A.R.T. Advisors
New York
– -$216K -26,703 Closed
D.E. Shaw & Co
81
D.E. Shaw & Co
New York
– -$174K -21,583 Closed
VF
82
Virtu Financial
New York
– -$92K -11,379 Closed
Man Group
83
Man Group
United Kingdom
– -$83K -10,334 Closed
Wolverine Trading
84
Wolverine Trading
Illinois
– -$78.8K -10,124 Closed
SI
85
Stephens Inc
Arkansas
– -$81K -10,000 Closed
Marshall Wace
86
Marshall Wace
United Kingdom
– -$33K -4,025 Closed
SFA
87
Semmax Financial Advisors
North Carolina
– -$11K -1,377 Closed
Bank of Montreal
88
Bank of Montreal
Ontario, Canada
– -$4K -434 Closed
Carson Wealth (CWM LLC)
89
Carson Wealth (CWM LLC)
Nebraska
– -$3K -362 Closed
PCM
90
Prelude Capital Management
New York
– -$1K -136 Closed
APC
91
Aspire Private Capital
North Carolina
– -$662 -85 Closed
1 2 3
4

CTSO Hedge Fund Activity: Q1 2019 in Review

77 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2019, worth a combined $64.6M — down 7.7% from $69.9M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of CTSO and 7 opened new positions — a net loss of 8 holders — while 23 trimmed existing stakes and 26 added.

The largest buyer was Skylands Capital, adding an estimated $1.09M. The largest seller was Manatuck Hill Partners, exiting entirely with an estimated $1.57M sold.

  • 77 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2019, down from 85 in Q4 2018.
  • Funds reported $64.6M of Cytosorbents Corp stock for Q1 2019, down 7.7% quarter-over-quarter.
  • 7 funds opened new Cytosorbents Corp positions in Q1 2019 and 15 closed out, a net change of -8 holders.
  • The largest Cytosorbents Corp buyer in Q1 2019 was Skylands Capital, an estimated $1.09M added.
  • The largest Cytosorbents Corp seller in Q1 2019 was Manatuck Hill Partners, an estimated $1.57M sold.

Based on aggregated 13F filings for Q1 2019.